Post-Authorisation Safety Study of Lesinurad

Trial Identifier:	D5310R00016
Sponsor:	AstraZeneca
NCTID::	NCT04072471
Start Date:	January 2021
Primary Completion Date:	June 2023
Study Completion Date:	June 2023
Condition:	Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.